Margriet Collée

5.3k total citations
13 papers, 411 citations indexed

About

Margriet Collée is a scholar working on Genetics, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Margriet Collée has authored 13 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 6 papers in Reproductive Medicine and 5 papers in Cancer Research. Recurrent topics in Margriet Collée's work include BRCA gene mutations in cancer (12 papers), Cancer Genomics and Diagnostics (4 papers) and Prenatal Screening and Diagnostics (4 papers). Margriet Collée is often cited by papers focused on BRCA gene mutations in cancer (12 papers), Cancer Genomics and Diagnostics (4 papers) and Prenatal Screening and Diagnostics (4 papers). Margriet Collée collaborates with scholars based in Netherlands, United States and Nepal. Margriet Collée's co-authors include Maartje J. Hooning, Caroline Seynaeve, Agnes Jager, Mieke Kriege, Curt W. Burger, P.M.L.H. Vencken, E. Berns, M.E.L. van der Burg, Margreet G.E.M. Ausems and Christi J. van Asperen and has published in prestigious journals such as Cancer, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Margriet Collée

13 papers receiving 406 citations

Peers

Margriet Collée

GENET

ONCOL

Jeanna McCuaig Canada

Faiza Gaba United Kingdom

Anne‐Bine Skytte Denmark

Jacquelyn Powers United States

B.A.M. Heemskerk-Gerritsen Netherlands

Ingrid Slade United Kingdom

J.M. Collée Netherlands

Steven A. Narod Canada

Ann Strydom United Kingdom

Julie Erlichman United States

Jeanna McCuaig Canada

Margriet Collée

320 ×1.1

GENET

101 ×0.6

158 ×1.0

ONCOL

139 ×1.2

103 ×1.0

Citations per year, relative to Margriet Collée Margriet Collée (= 1×) peers Jeanna McCuaig

Countries citing papers authored by Margriet Collée

Since Specialization

Citations

This map shows the geographic impact of Margriet Collée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margriet Collée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margriet Collée more than expected).

Fields of papers citing papers by Margriet Collée

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margriet Collée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margriet Collée. The network helps show where Margriet Collée may publish in the future.

Co-authorship network of co-authors of Margriet Collée

This figure shows the co-authorship network connecting the top 25 collaborators of Margriet Collée. A scholar is included among the top collaborators of Margriet Collée based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margriet Collée. Margriet Collée is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Schaapveld, Michael, Marjoleine F. Broekema, Margriet Collée, et al.. (2024). Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families. Genetics in Medicine. 26(9). 101171–101171. 2 indexed citations

Boekel, Naomi B., Maartje J. Hooning, Margriet Collée, et al.. (2024). Cardiovascular disease risk after breast cancer treatment in patients with a BRCA1/2 pathogenic variant. Breast Cancer Research and Treatment. 209(3). 573–583. 1 indexed citations

Dulmen, Sandra van, Mary E. Velthuizen, Maria van den Muijsenbergh, et al.. (2021). Effect of a health literacy training program for surgical oncologists and specialized nurses on disparities in referral to breast cancer genetic testing. The Breast. 58. 80–87. 10 indexed citations

Kuijk, Sander M. J. van, Cora M. Aalfs, Christi J. van Asperen, et al.. (2020). Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making. Journal of Community Genetics. 12(1). 101–110. 9 indexed citations

Heemskerk‐Gerritsen, Bernadette A. M., Agnes Jager, Linetta B. Koppert, et al.. (2019). Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 177(3). 723–733. 114 indexed citations

Hogervorst, Frans B.L., Mary E. Velthuizen, Mariëlle Ruijs, et al.. (2019). TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort. Familial Cancer. 18(2). 273–280. 22 indexed citations

Derks-Smeets, I. A. P., Christine de Die‐Smulders, Vivianne C. G. Tjan‐Heijnen, et al.. (2018). Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers. British Journal of Cancer. 119(3). 357–363. 17 indexed citations

Kuijk, Sander M. J. van, Cora M. Aalfs, Christi J. van Asperen, et al.. (2018). The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study. Familial Cancer. 18(1). 137–146. 18 indexed citations

Kuijk, Sander M. J. van, Cora M. Aalfs, Christi J. van Asperen, et al.. (2018). Online decision support for persons having a genetic predisposition to cancer and their partners during reproductive decision‐making. Journal of Genetic Counseling. 28(3). 533–542. 15 indexed citations

10.

Wevers, Marijke R., Marjanka K. Schmidt, Ellen G. Engelhardt, et al.. (2015). Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study. Familial Cancer. 14(3). 355–363. 11 indexed citations

11.

Vos, Janet R., Dorina M. van der Kolk, Marian J.E. Mourits, et al.. (2014). Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands. Cancer Epidemiology Biomarkers & Prevention. 23(11). 2482–2491. 8 indexed citations

12.

Vencken, P.M.L.H., Mieke Kriege, Maartje J. Hooning, et al.. (2012). The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers. Cancer. 119(5). 955–962. 30 indexed citations

13.

Vencken, P.M.L.H., Mieke Kriege, M.E.L. van der Burg, et al.. (2011). Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients. Annals of Oncology. 22(6). 1346–1352. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact